Skip to main content

STAAR SURGICAL CO

For the period ended Jan 2, 2026. Filed Mar 3, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Mar 3, 2026

STAA$23.87-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEM ENTS OF CASH FLOWS

202520242023
Cash flows from operating activities:
Net income (loss)$(80,448)$(20,208)$21,347
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation of property, plant, and equipment8,3196,8915,111
Amortization of cloud-based software409——
Non-cash operating lease expense3,5703,5623,256
Impairment of fixed assets and operating lease right-of-use assets15,404——
Gain on fixed asset recovery(1,458)——
Amortization of intangibles——13
Impairment of intangibles——154
Accretion/amortization of investments available for sale(198)(1,091)(2,501)
Deferred income taxes(2,916)3,5903,264
Change in net pension liability(249)26(956)
Loss on disposal of property and equipment741,69473
Stock-based compensation expense30,58827,21023,516
Change in asset retirement obligation4(53)(102)
Provision for sales returns and credit losses3,664286663
Inventory provision5,3342,7824,851
Changes in working capital:
Accounts receivable27,83416,493(32,760)
Inventories(16,981)(10,000)(14,361)
Prepayments, deposits, and other assets(1,352)(2,006)(1,007)
Cloud-based software(15,764)(13,357)(2,406)
Accounts payable(5,507)75(701)
Other current liabilities and non-current liabilities(4,557)(169)7,140
Net cash provided by (used in) operating activities(34,230)15,72514,594
Cash flows from investing activities:
Acquisition of property and equipment(5,820)(23,394)(18,188)
Purchase of investments available for sale(75,363)(80,240)(52,313)
Proceeds from maturity of investments available for sale124,14543,103143,548
Proceeds from sale of investments available for sale3,3771,3141,300
Net cash provided by (used in) investing activities46,339(59,217)74,347
Cash flows from financing activities:
Repayment of finance lease obligations(42)(165)(161)
Repurchase of common stock(6,461)——
Repurchase of employee common stock for taxes withheld(1,520)(1,505)(2,097)
Proceeds from the exercise of stock options3,4657,3929,672
Proceeds from vested restricted and performance stock units321
Net cash provided by (used in) financing activities(4,555)5,7247,415
Effect of exchange rate changes on cash and cash equivalents1,437(1,111)202
Increase (decrease) in cash and cash equivalents8,991(38,879)96,558
Cash and cash equivalents, at beginning of year144,159183,03886,480
Cash and cash equivalents, at end of year$153,150$144,159$183,038
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.